Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dyax, Bill Barrett, MeetMe: What You Need To Know About Today’s Hottest Stocks

Page 1 of 2

Shares of Dyax Corp. (NASDAQ:DYAX), Bill Barrett Corporation (NYSE:BBG), and MeetMe Inc (NASDAQ:MEET) are up by 12.5%, 11.1%, and 15% respectively in afternoon trading today, at a time when the S&P 500 is up by just 0.9% and the NASDAQ is up by 1%. Given the relative strength of the three, let’s find out why investors are hitting the buy buttons and examine notable hedge fund activity concerning them, if any.

Largest Stock Exchanges in Asia by Volume

Dyax Corp. (NASDAQ:DYAX), a drug company focused on developing orphan treatments for rare blood disorders, is up as sentiment around the sector improves. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) is up by more than 2% as investors become less concerned about potential pricing ceilings and new regulations. Being able to optimize prices for the market is very important for Dyax Corp, as the company doesn’t exactly make drugs for the masses (it makes orphan drugs). Shares of the company have done very well so far, with shares up by over 70% year-to-date.

Within our extensive database of 730 elite funds, hedge funds are bullish on Dyax Corp. (NASDAQ:DYAX). 33 elite funds were long Dyax at the end of the second quarter, up by five from the previous quarter. The funds’ collective holdings in Dyax was $714.6 million (representing 18.5% of the float), up by $5.3 million from the end of March. Julian Baker and Felix Baker‘s Baker Bros Advisors, one of the top performing funds this year, increased its position in the stock by 32% to 7.93 million shares during the April-to-June period.

Follow Dyax Corp (NASDAQ:DYAX)
Trade (NASDAQ:DYAX) Now!

We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 102% since then and outperformed the S&P 500 Index by around 53 percentage points (see the details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

On the next page we’ll look at why investors are excited about Bill Barrett and MeetMe.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!